Icotinib Hydrochloride

CAS : 1204313-51-8

Ref. TM-T2307

Informations sur le produit

• Nom: Icotinib Hydrochloride
• Synonymes: BPI-2009H
• CAS: 1204313-51-8

Description

Icotinib Hydrochloride (BPI-2009H) is the hydrochloride salt form of icotinib, an orally available quinazoline-based inhibitor of EGFR, with potential antineoplastic activity. Icotinib selectively inhibits the wild-type and several mutated forms of EGFR tyrosine kinase. This may lead to an inhibition of EGFR-mediated signal transduction and may inhibit cancer cell proliferation. EGFR, a receptor tyrosine kinase, has been upregulated in a variety of cancer cell types.

• Marque: Targetmol

Propriétés chimiques

• Masse moléculaire: 427.88
• Formule: C₂₂H₂₂ClN₃O₄
• Degré de pureté: 99.77%
• Couleur/Forme: Solid